Suppr超能文献

与传统授精相比,胞浆内单精子注射在非男性因素不孕的情况下没有益处,证据是其整倍体率相当。

Compared with conventional insemination, intracytoplasmic sperm injection provides no benefit in cases of nonmale factor infertility as evidenced by comparable euploidy rate.

机构信息

Department of Obstetrics and Gynecology, Tufts Medical Center, Boston, Massachusetts.

Boston IVF - The Eugin Group, Waltham, Massachusetts; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, Massachusetts.

出版信息

Fertil Steril. 2023 Aug;120(2):277-286. doi: 10.1016/j.fertnstert.2023.04.020. Epub 2023 Apr 20.

Abstract

OBJECTIVE

To evaluate whether differences in euploidy rates exist between intracytoplasmic sperm injection (ICSI) and conventional insemination (CI) in nonmale factor infertility cases.

DESIGN

Retrospective cohort study.

SETTING

A single, academically affiliated infertility center in the United States.

PATIENTS

A total of 3554 patients who underwent in vitro fertilization cycles from January 2014 to December 2021. All cycles that had preimplantation testing for aneuploidy (PGT-A) performed by trophectoderm biopsy and had a postpreparation sperm concentration >4 million total motile sperm per milliliter were included.

MAIN OUTCOME MEASURES

The primary outcome was the embryo euploidy rate per embryo biopsied in the ICSI vs. CI group. Secondary outcomes included the fertilization rate and number of embryos biopsied. Generalized estimating equations with a Poisson distribution were used to estimate the euploid rate ratio (with total embryos biopsied as an offset), while accounting for multiple retrievals per patient. To adjust for confounding, a propensity score model was fit for ICSI using 14 baseline female and male characteristics.

RESULTS

Oocytes retrieved and the number of embryos biopsied were similar in both groups, while the fertilization rate per oocyte retrieved was significantly lower with ICSI (0.64 vs. 0.66). The proportion of euploid embryos in the ICSI group was significantly lower when compared with CI (0.47 vs. 0.52), with a euploid rate ratio of 0.89. Interestingly, when accounting for the variation in PGT reference laboratories over the study time period, adjusting for the date of procedure did not change the relationship between ICSI and euploid rate (rate ratio = 0.89); however, after adjusting for the PGT reference laboratory, the relationship between ICSI and euploid rate was no longer significant (rate ratio = 0.97).

CONCLUSIONS

In the setting of nonmale factor infertility, ICSI resulted in a lower fertilization rate and an 11% lower embryo euploid rate compared with CI. Although the data are not statistically significant when adjusted for the PGT reference laboratory, we still can conclude that ICSI does not provide any benefit. These data support the recommendation that CI should be the preferred methodology for fertilization in nonmale factor infertility cases.

摘要

目的

评估在非男性因素不孕病例中,卵胞浆内单精子注射(ICSI)与常规授精(CI)之间是否存在胚胎整倍体率的差异。

设计

回顾性队列研究。

地点

美国的一家单一的、学术附属的不孕不育中心。

患者

2014 年 1 月至 2021 年 12 月期间进行体外受精周期的共 3554 名患者。所有周期均进行了胚胎植入前遗传学检测(PGT-A),通过滋养层活检进行,且准备后精子浓度>每毫升 400 万个总活动精子。

主要观察指标

主要结局为 ICSI 与 CI 组中每个胚胎活检的胚胎整倍体率。次要结局包括受精率和活检胚胎数量。使用泊松分布广义估计方程来估计整倍体率比(以总活检胚胎数为偏移量),同时考虑到每个患者的多次采集。为了调整混杂因素,使用 14 个基线女性和男性特征为 ICSI 拟合倾向评分模型。

结果

两组的卵母细胞采集数和活检胚胎数相似,而 ICSI 组的每卵母细胞受精率显著降低(0.64 比 0.66)。与 CI 相比,ICSI 组中整倍体胚胎的比例显著降低(0.47 比 0.52),整倍体率比为 0.89。有趣的是,当考虑研究期间 PGT 参考实验室的变化时,调整程序日期并不能改变 ICSI 与整倍体率之间的关系(率比=0.89);然而,调整 PGT 参考实验室后,ICSI 与整倍体率之间的关系不再显著(率比=0.97)。

结论

在非男性因素不孕的情况下,与 CI 相比,ICSI 导致受精率降低 11%,胚胎整倍体率降低 11%。尽管在调整 PGT 参考实验室后数据没有统计学意义,但我们仍然可以得出结论,ICSI 没有带来任何益处。这些数据支持建议在非男性因素不孕病例中,CI 应该是首选的受精方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验